市場調査レポート

商品コード

1405860

ヘパリンの市場規模、シェア、動向分析レポート：タイプ別、投与経路別、最終用途別、由来別、地域別、セグメント予測、2024年～2030年

Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2023年12月15日 | 発行: Grand View Research

| ページ情報: 英文 111 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 939,505円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,097,405円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,413,205円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ヘパリン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヘパリンの市場規模は、2024年から2030年にかけてCAGR 2.7%で拡大し、2030年までには90億3,000万米ドルに達する見込みです。

高齢者人口の増加と輸血需要の高まりが市場成長を促進する主な要因です。さらに、COVID-19の発生が市場成長をさらに促進しています。例えば、2022年のThe Lancet Journalによると、血栓予防のためにCOVID-19患者に使用されたことに起因して、ヘパリンの需要が悪化しました。

感染症治療における血液成分、輸血、血漿誘導体の需要の増加が市場を牽引すると予想されます。例えば、2022年の米国赤十字社によると、米国では毎年約1,600万個の血液成分が輸血されています。さらに、COVID-19パンデミックのために延期された手術件数の急増が、血栓予防のためのヘパリン需要をさらにエスカレートさせています。

高齢者人口の増加は市場の成長を促進すると推定されます。国連によると、2020年には世界で60歳以上の人口が約7億2,700万人になると推定されています。また、65歳以上の高齢者人口に占める割合は、2020年の9.3%から2050年には16%に増加すると推定されています。高齢者人口は複雑な手術を受ける割合が高いため、血栓や深部静脈血栓症などの関連疾患を発症する割合が著しく高く、抗凝固剤としてのヘパリン需要を促進すると予想されます。

手術件数の増加は、全血および輸血の需要を加速させる重要な要因です。例えば、世界で行われる大手術の年間件数は3億1,000万件に達し、米国では4,000万から5,000万件、欧州では約2,000万件が2020年に行われました。これらの手術はヘパリンの需要をエスカレートさせると予測されています。

経口抗凝固薬に対するダイナミクスが変化しているため、マーケットプレースでの競争企業間の敵対関係は緩やかなものになると予想されます。ヘパリンのような抗凝固剤の新規投与経路の発見にプレーヤーが関与することで、予測期間中の市場シナリオは変化すると予想されます。また、ジェネリック医薬品を提供するプレーヤーが増加していることも、競争企業間の敵対関係を高めています。

ヘパリン市場レポートハイライト

低分子ヘパリン（LMWH）セグメントは、その高い処方率と需要により、2023年に最大の売上シェアを占めました。
皮下投与経路セグメントは、費用対効果が高く、投与手順が容易であることから、2023年に最大の売上シェアを占めました。
冠動脈疾患セグメントは、冠動脈疾患の罹患率の上昇と入院患者におけるヘパリン注射の使用増加により、2022年の市場を独占しました。
2023年には、病院による外来患者向けサービスの取り組みと、外来治療を好む患者の増加により、外来患者セグメントが最大の収益シェアを占めると予想されます。
ポルシン由来のヘパリンは、低分子ヘパリンの生産に使用されるため、市場を独占すると予想されます。
アジア太平洋地域は、ヘルスケアの確立が進み、人口が多いため、予測期間中に最も速い成長を示すと予想されます。

地域市場シェア分析、2023年・2030年
地域市場ダッシュボード
世界の地域市場のスナップショット
市場規模と予測トレンド分析、2018年～2030年
北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- スウェーデン
- デンマーク
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第10章競合情勢

主要市場参入企業による最近の動向と影響分析
会社/競合の分類
ベンダー情勢
- List of key distributors and channel partners
- Key customers
- Key company market share analysis, 2023
- Pfizer Inc.
- LEO Pharma A/S
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline plc
- Sanofi
- Aspen Holdings
- Fresenius SE &Co. KGaA
- B. Braun Medical, Inc.
- Sandoz（Novartis AG）

図表

List of Tables

Table 1 List of abbreviations
Table 2 North America Heparin market, by region, 2018 - 2030 (USD Million)
Table 3 North America Heparin market, by type, 2018 - 2030 (USD Million)
Table 4 North America Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 5 North America Heparin market, by application, 2018 - 2030 (USD Million)
Table 6 North America Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America Heparin market, by source, 2018 - 2030 (USD Million)
Table 8 U.S. Heparin market, by type, 2018 - 2030 (USD Million)
Table 9 U.S. Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 10 U.S. Heparin market, by application, 2018 - 2030 (USD Million)
Table 11 U.S. Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.S. Heparin market, by source, 2018 - 2030 (USD Million)
Table 13 Canada Heparin market, by type, 2018 - 2030 (USD Million)
Table 14 Canada Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Canada Heparin market, by application, 2018 - 2030 (USD Million)
Table 16 Canada Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada Heparin market, by source, 2018 - 2030 (USD Million)
Table 18 Europe Heparin market, by region, 2018 - 2030 (USD Million)
Table 19 Europe Heparin market, by type, 2018 - 2030 (USD Million)
Table 20 Europe Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 21 Europe Heparin market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 23 Europe Heparin market, by source, 2018 - 2030 (USD Million)
Table 24 Germany Heparin market, by type, 2018 - 2030 (USD Million)
Table 25 Germany Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 26 Germany Heparin market, by application, 2018 - 2030 (USD Million)
Table 27 Germany Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 28 Germany Heparin market, by source, 2018 - 2030 (USD Million)
Table 29 UK Heparin market, by type, 2018 - 2030 (USD Million)
Table 30 UK Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 31 UK Heparin market, by application, 2018 - 2030 (USD Million)
Table 32 UK Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 33 UK Heparin market, by source, 2018 - 2030 (USD Million)
Table 34 France Heparin market, by type, 2018 - 2030 (USD Million)
Table 35 France Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 36 France Heparin market, by application, 2018 - 2030 (USD Million)
Table 37 France Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 38 France Heparin market, by source, 2018 - 2030 (USD Million)
Table 39 Italy Heparin market, by type, 2018 - 2030 (USD Million)
Table 40 Italy Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 41 Italy Heparin market, by application, 2018 - 2030 (USD Million)
Table 42 Italy Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 43 Italy Heparin market, by source, 2018 - 2030 (USD Million)
Table 44 Spain Heparin market, by type, 2018 - 2030 (USD Million)
Table 45 Spain Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 46 Spain Heparin market, by application, 2018 - 2030 (USD Million)
Table 47 Spain Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 48 Spain Heparin market, by source, 2018 - 2030 (USD Million)
Table 49 Denmark Heparin market, by type, 2018 - 2030 (USD Million)
Table 50 Denmark Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 51 Denmark Heparin market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 53 Denmark Heparin market, by source, 2018 - 2030 (USD Million)
Table 54 Sweden Heparin market, by type, 2018 - 2030 (USD Million)
Table 55 Sweden Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Sweden Heparin market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 58 Sweden Heparin market, by source, 2018 - 2030 (USD Million)
Table 59 Norway Heparin market, by type, 2018 - 2030 (USD Million)
Table 60 Norway Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Norway Heparin market, by application, 2018 - 2030 (USD Million)
Table 62 Norway Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 63 Norway Heparin market, by source, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Heparin market, by region, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Heparin market, by type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Heparin market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific Heparin market, by source, 2018 - 2030 (USD Million)
Table 70 China Heparin market, by type, 2018 - 2030 (USD Million)
Table 71 China Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 72 China Heparin market, by application, 2018 - 2030 (USD Million)
Table 73 China Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 74 China Heparin market, by source, 2018 - 2030 (USD Million)
Table 75 Japan Heparin market, by type, 2018 - 2030 (USD Million)
Table 76 Japan Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 77 Japan Heparin market, by application, 2018 - 2030 (USD Million)
Table 78 Japan Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 79 Japan Heparin market, by source, 2018 - 2030 (USD Million)
Table 80 India Heparin market, by type, 2018 - 2030 (USD Million)
Table 81 India Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 82 India Heparin market, by application, 2018 - 2030 (USD Million)
Table 83 India Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 84 India Heparin market, by source, 2018 - 2030 (USD Million)
Table 85 South Korea Heparin market, by type, 2018 - 2030 (USD Million)
Table 86 South Korea Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 87 South Korea Heparin market, by application, 2018 - 2030 (USD Million)
Table 88 South Korea Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 89 South Korea Heparin market, by source, 2018 - 2030 (USD Million)
Table 90 Australia Heparin market, by type, 2018 - 2030 (USD Million)
Table 91 Australia Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 92 Australia Heparin market, by application, 2018 - 2030 (USD Million)
Table 93 Australia Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 94 Australia Heparin market, by source, 2018 - 2030 (USD Million)
Table 95 Thailand Heparin market, by type, 2018 - 2030 (USD Million)
Table 96 Thailand Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 97 Thailand Heparin market, by application, 2018 - 2030 (USD Million)
Table 98 Thailand Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 99 Thailand Heparin market, by source, 2018 - 2030 (USD Million)
Table 100 Latin America Heparin market, by region, 2018 - 2030 (USD Million)
Table 101 Latin America Heparin market, by type, 2018 - 2030 (USD Million)
Table 102 Latin America Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 103 Latin America Heparin market, by application, 2018 - 2030 (USD Million)
Table 104 Latin America Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 105 Latin America Heparin market, by source, 2018 - 2030 (USD Million)
Table 106 Brazil Heparin market, by type, 2018 - 2030 (USD Million)
Table 107 Brazil Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 108 Brazil Heparin market, by application, 2018 - 2030 (USD Million)
Table 109 Brazil Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 110 Brazil Heparin market, by source, 2018 - 2030 (USD Million)
Table 111 Mexico Heparin market, by type, 2018 - 2030 (USD Million)
Table 112 Mexico Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 113 Mexico Heparin market, by application, 2018 - 2030 (USD Million)
Table 114 Mexico Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 115 Mexico Heparin market, by source, 2018 - 2030 (USD Million)
Table 116 Argentina Heparin market, by type, 2018 - 2030 (USD Million)
Table 117 Argentina Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 118 Argentina Heparin market, by application, 2018 - 2030 (USD Million)
Table 119 Argentina Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 120 Argentina Heparin market, by source, 2018 - 2030 (USD Million)
Table 121 MEA Heparin market, by region, 2018 - 2030 (USD Million)
Table 122 MEA Heparin market, by type, 2018 - 2030 (USD Million)
Table 123 MEA Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 124 MEA Heparin market, by application, 2018 - 2030 (USD Million)
Table 125 MEA Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 126 MEA Heparin market, by source, 2018 - 2030 (USD Million)
Table 127 South Africa Heparin market, by type, 2018 - 2030 (USD Million)
Table 128 South Africa Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 129 South Africa Heparin market, by application, 2018 - 2030 (USD Million)
Table 130 South Africa Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 131 South Africa Heparin market, by source, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia Heparin market, by type, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia Heparin market, by application, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia Heparin market, by source, 2018 - 2030 (USD Million)
Table 137 UAE Heparin market, by type, 2018 - 2030 (USD Million)
Table 138 UAE Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 139 UAE Heparin market, by application, 2018 - 2030 (USD Million)
Table 140 UAE Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 141 UAE Heparin market, by source, 2018 - 2030 (USD Million)
Table 142 Kuwait Heparin market, by type, 2018 - 2030 (USD Million)
Table 143 Kuwait Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 144 Kuwait Heparin market, by application, 2018 - 2030 (USD Million)
Table 145 Kuwait Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 146 Kuwait Heparin market, by source, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Heparin market: market outlook
Fig. 14 Heparin competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Heparin market driver impact
Fig. 20 Heparin market restraint impact
Fig. 21 Heparin market strategic initiatives analysis
Fig. 22 Heparin market: Type movement analysis
Fig. 23 Heparin market: Type outlook and key takeaways
Fig. 24 Low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Ultra-low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Unfractionated Heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Heparin market: Route of Administration movement Analysis
Fig. 28 Heparin market: Route of Administration outlook and key takeaways
Fig. 29 Intravenous market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Subcutaneous market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Heparin market: Application movement analysis
Fig. 32 Heparin market: Application outlook and key takeaways
Fig. 33 Venous thromboembolism market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Atrial fibrillation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Renal impairment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Coronary artery disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Heparin market: End-use movement analysis
Fig. 39 Heparin market: End-use outlook and key takeaways
Fig. 40 Outpatient market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Inpatient market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Heparin market: Source movement analysis
Fig. 43 Heparin market: Source outlook and key takeaways
Fig. 44 Porcine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Bovine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Global Heparin market: Regional movement analysis
Fig. 48 Global Heparin market: Regional outlook and key takeaways
Fig. 49 Global Heparin market share and leading players
Fig. 50 North America market share and leading players
Fig. 51 Europe market share and leading players
Fig. 52 Asia Pacific market share and leading players
Fig. 53 Latin America market share and leading players
Fig. 54 Middle East & Africa market share and leading players
Fig. 55 North America: SWOT
Fig. 56 Europe SWOT
Fig. 57 Asia Pacific SWOT
Fig. 58 Latin America SWOT
Fig. 59 MEA SWOT
Fig. 60 North America, by country
Fig. 61 North America
Fig. 62 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 U.S.
Fig. 64 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Canada
Fig. 66 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Europe
Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UK
Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Germany
Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 France
Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Italy
Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Spain
Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Denmark
Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Sweden
Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Norway
Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Asia Pacific
Fig. 86 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 China
Fig. 88 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Japan
Fig. 90 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 India
Fig. 92 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Thailand
Fig. 94 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 South Korea
Fig. 96 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Australia
Fig. 98 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Latin America
Fig. 100 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Brazil
Fig. 102 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Mexico
Fig. 104 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Argentina
Fig. 106 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Middle East and Africa
Fig. 108 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 South Africa
Fig. 110 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Saudi Arabia
Fig. 112 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 UAE
Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Kuwait
Fig. 116 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Market share of key market players- Heparin market

Product Code: GVR-3-68038-154-2

Heparin Market Growth & Trends:

The global heparin market size is expected to reach USD 9.03 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing geriatric population and heightened demand for transfusions are key factors propelling the market growth. Moreover, the outbreak of COVID-19 has further propelled the market growth. For instance, as per The Lancet Journal in 2022, the demand for heparin exacerbated attributable to its use in COVID-19 patients for thromboprophylaxis.

Increasing demand for blood components, transfusion, and plasma derivatives in the treatment of infectious diseases is expected to drive the market. For instance, according to American Red Cross in 2022, around 16 million blood components are transfused each year in the U.S. Furthermore, the surge in the number of surgeries that were delayed due to the COVID-19 pandemic has further escalated the demand for heparin for blood-clot prevention.

The growing geriatric population is estimated to fuel the market growth. According to United Nations, it was estimated that, in 2020, there were around 727 million people with ages above 60 years worldwide. In addition, the percentage share of the aged population above 65 years is estimated to increase from 9.3% in 2020 to 16% in 2050. The geriatric population has a higher rate of complex surgeries and thus is anticipated to propel the demand for heparin as an anticoagulant, as this population has a significantly higher rate of developing blood clots and related conditions such as deep vein thrombosis.

The growing number of surgeries is a key factor accelerating the demand for whole blood and transfusions. For instance, the annual number of major surgeries performed globally has reached 310 million, 40 to 50 million surgeries performed in the U.S., and around 20 million were performed in Europe in 2020. These surgeries are projected to escalate the demand for heparin.

The competitive rivalry in the marketplace is expected to be moderate due to changing dynamics towards oral anticoagulants. The involvement of players in discovering novel routes of administration for anticoagulants such as heparin is expected to change the market scenario over the forecast period. The rising number of players offering generics also increases competitive rivalry.

Heparin Market Report Highlights:

The Low Molecular Weight Heparin (LMWH) segment held the largest revenue share in 2023 owing to its high prescription rate and demand
The subcutaneous route of administration segment held the largest revenue share in 2023 owing to its cost-effective nature and easier procedure for administration
The coronary artery disease segment dominated the market in 2022 owing to the rising incidence of coronary artery disease and increased use of heparin injection in hospitalized patients
The outpatient segment is expected to hold the largest revenue share in 2023 owing to the initiatives undertaken by hospitals for outpatient services and the increased preference of patients for outpatient treatment
Porcine-derived heparin is expected to dominate the market due to its use in the production of low molecular weight heparin
Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing establishment of healthcare, and a large population base

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Route of administration
- 1.2.3. Application
- 1.2.4. End-use
- 1.2.5. Source
- 1.2.6. Regional scope
- 1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type
- 2.2.2. Route of Administration
- 2.2.3. Application
- 2.2.4. End-use
- 2.2.5. Source
- 2.2.6. Regional outlook
2.3. Competitive Insights

Chapter 3. Heparin Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of chronic diseases
  - 3.2.1.2. Growing demand for whole blood and blood components transfusion
  - 3.2.1.3. Increasing geriatric population
  - 3.2.1.4. High usage of plasma in the pharmaceutical industry
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Risk of blood-transmitted diseases and an increasing number of blood substitutes
  - 3.2.2.2. Emerging oral anticoagulants
3.3. Heparin Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Heparin Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Heparin Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Low Molecular Weight Heparin
  - 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Ultra-low Molecular Weight Heparin
  - 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Unfractionated Heparin
  - 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis

5.1. Route of Administration Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Heparin Market by Route of Administration Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Intravenous
  - 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Subcutaneous
  - 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Heparin Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Heparin Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Venous Thromboembolism
  - 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Atrial Fibrillation
  - 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Renal Impairment
  - 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.4. Coronary Artery Disease
  - 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.5. Others
  - 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Heparin Market: End-use Estimates & Trend Analysis

7.1. End-use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Heparin Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4.1. Outpatient
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Inpatient
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Heparin Market: Source Estimates & Trend Analysis

8.1. Source Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Heparin Market by Source Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.4.1. Porcine
  - 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Bovine
  - 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Others
  - 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Heparin Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.5. North America
- 9.5.1. U.S.
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/ reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Canada
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/ reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
9.6. Europe
- 9.6.1. UK
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/ reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Germany
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/ reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.3. France
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Regulatory framework/ reimbursement structure
  - 9.6.3.3. Competitive scenario
  - 9.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.4. Italy
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Regulatory framework/ reimbursement structure
  - 9.6.4.3. Competitive scenario
  - 9.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Spain
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Regulatory framework/ reimbursement structure
  - 9.6.5.3. Competitive scenario
  - 9.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.6. Norway
  - 9.6.6.1. Key country dynamics
  - 9.6.6.2. Regulatory framework/ reimbursement structure
  - 9.6.6.3. Competitive scenario
  - 9.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Sweden
  - 9.6.7.1. Key country dynamics
  - 9.6.7.2. Regulatory framework/ reimbursement structure
  - 9.6.7.3. Competitive scenario
  - 9.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.8. Denmark
  - 9.6.8.1. Key country dynamics
  - 9.6.8.2. Regulatory framework/ reimbursement structure
  - 9.6.8.3. Competitive scenario
  - 9.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
9.7. Asia Pacific
- 9.7.1. Japan
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/ reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.7.2. China
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/ reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.7.3. India
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/ reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.7.4. Australia
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/ reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.7.5. South Korea
  - 9.7.5.1. Key country dynamics
  - 9.7.5.2. Regulatory framework/ reimbursement structure
  - 9.7.5.3. Competitive scenario
  - 9.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.7.6. Thailand
  - 9.7.6.1. Key country dynamics
  - 9.7.6.2. Regulatory framework/ reimbursement structure
  - 9.7.6.3. Competitive scenario
  - 9.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
9.8. Latin America
- 9.8.1. Brazil
  - 9.8.1.1. Key country dynamics
  - 9.8.1.2. Regulatory framework/ reimbursement structure
  - 9.8.1.3. Competitive scenario
  - 9.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.8.2. Mexico
  - 9.8.2.1. Key country dynamics
  - 9.8.2.2. Regulatory framework/ reimbursement structure
  - 9.8.2.3. Competitive scenario
  - 9.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Argentina
  - 9.8.3.1. Key country dynamics
  - 9.8.3.2. Regulatory framework/ reimbursement structure
  - 9.8.3.3. Competitive scenario
  - 9.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
9.9. MEA
- 9.9.1. South Africa
  - 9.9.1.1. Key country dynamics
  - 9.9.1.2. Regulatory framework/ reimbursement structure
  - 9.9.1.3. Competitive scenario
  - 9.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.9.2. Saudi Arabia
  - 9.9.2.1. Key country dynamics
  - 9.9.2.2. Regulatory framework/ reimbursement structure
  - 9.9.2.3. Competitive scenario
  - 9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.9.3. UAE
  - 9.9.3.1. Key country dynamics
  - 9.9.3.2. Regulatory framework/ reimbursement structure
  - 9.9.3.3. Competitive scenario
  - 9.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.9.4. Kuwait
  - 9.9.4.1. Key country dynamics
  - 9.9.4.2. Regulatory framework/ reimbursement structure
  - 9.9.4.3. Competitive scenario
  - 9.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company market share analysis, 2023
- 10.3.4. Pfizer Inc.
  - 10.3.4.1. Company overview
  - 10.3.4.2. Financial performance
  - 10.3.4.3. Type benchmarking
  - 10.3.4.4. Strategic initiatives
- 10.3.5. LEO Pharma A/S
  - 10.3.5.1. Company overview
  - 10.3.5.2. Financial performance
  - 10.3.5.3. Type benchmarking
  - 10.3.5.4. Strategic initiatives
- 10.3.6. Dr. Reddy's Laboratories Ltd.
  - 10.3.6.1. Company overview
  - 10.3.6.2. Financial performance
  - 10.3.6.3. Type benchmarking
  - 10.3.6.4. Strategic initiatives
- 10.3.7. GlaxoSmithKline plc
  - 10.3.7.1. Company overview
  - 10.3.7.2. Financial performance
  - 10.3.7.3. Type benchmarking
  - 10.3.7.4. Strategic initiatives
- 10.3.8. Sanofi
  - 10.3.8.1. Company overview
  - 10.3.8.2. Financial performance
  - 10.3.8.3. Type benchmarking
  - 10.3.8.4. Strategic initiatives
- 10.3.9. Aspen Holdings
  - 10.3.9.1. Company overview
  - 10.3.9.2. Financial performance
  - 10.3.9.3. Type benchmarking
  - 10.3.9.4. Strategic initiatives
- 10.3.10. Fresenius SE & Co. KGaA
  - 10.3.10.1. Company overview
  - 10.3.10.2. Financial performance
  - 10.3.10.3. Type benchmarking
  - 10.3.10.4. Strategic initiatives
- 10.3.11. B. Braun Medical, Inc.
  - 10.3.11.1. Company overview
  - 10.3.11.2. Financial performance
  - 10.3.11.3. Type benchmarking
  - 10.3.11.4. Strategic initiatives
- 10.3.12. Sandoz (Novartis AG)
  - 10.3.12.1. Company overview
  - 10.3.12.2. Financial performance
  - 10.3.12.3. Type benchmarking
  - 10.3.12.4. Strategic initiatives

ヘパリンの市場規模、シェア、動向分析レポート：タイプ別、投与経路別、最終用途別、由来別、地域別、セグメント予測、2024年～2030年

Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030

ヘパリン市場の成長と動向：

ヘパリン市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章ヘパリン市場の変数、動向、範囲

第4章ヘパリン市場：タイプの推定・動向分析

第5章ヘパリン市場：投与経路の推定・動向分析

第6章ヘパリン市場：用途の推定・動向分析

第7章ヘパリン市場：最終用途の推定・動向分析

第8章ヘパリン市場：由来の推定・動向分析

第9章ヘパリン市場：地域別の推定・動向分析

第10章競合情勢

List of Tables

List of Figures

Heparin Market Growth & Trends:

Heparin Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Heparin Market Variables, Trends & Scope

Chapter 4. Heparin Market: Type Estimates & Trend Analysis

Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis

Chapter 6. Heparin Market: Application Estimates & Trend Analysis

Chapter 7. Heparin Market: End-use Estimates & Trend Analysis

Chapter 8. Heparin Market: Source Estimates & Trend Analysis

Chapter 9. Heparin Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

ヘパリンの市場規模、シェア、動向分析レポート：タイプ別、投与経路別、最終用途別、由来別、地域別、セグメント予測、2024年～2030年

Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030

ヘパリン市場の成長と動向：

ヘパリン市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヘパリン市場の変数、動向、範囲

第4章 ヘパリン市場：タイプの推定・動向分析

第5章 ヘパリン市場：投与経路の推定・動向分析

第6章 ヘパリン市場：用途の推定・動向分析

第7章 ヘパリン市場：最終用途の推定・動向分析

第8章 ヘパリン市場：由来の推定・動向分析

第9章 ヘパリン市場：地域別の推定・動向分析

第10章 競合情勢

List of Tables

List of Figures

Heparin Market Growth & Trends:

Heparin Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Heparin Market Variables, Trends & Scope

Chapter 4. Heparin Market: Type Estimates & Trend Analysis

Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis

Chapter 6. Heparin Market: Application Estimates & Trend Analysis

Chapter 7. Heparin Market: End-use Estimates & Trend Analysis

Chapter 8. Heparin Market: Source Estimates & Trend Analysis

Chapter 9. Heparin Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章ヘパリン市場の変数、動向、範囲

第4章ヘパリン市場：タイプの推定・動向分析

第5章ヘパリン市場：投与経路の推定・動向分析

第6章ヘパリン市場：用途の推定・動向分析

第7章ヘパリン市場：最終用途の推定・動向分析

第8章ヘパリン市場：由来の推定・動向分析

第9章ヘパリン市場：地域別の推定・動向分析

第10章競合情勢